# Anifrolumab (Genetical Recombination) I.V. Infusion 300mg (サフネロー点滴静注３００ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3999462A1028). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3999462A1028
- **Product name (Japanese):** サフネロー点滴静注３００ｍｇ
- **English title:** Anifrolumab (Genetical Recombination) I.V. Infusion 300mg
- **Active ingredient:** アニフロルマブ（遺伝子組換え）
- **Active ingredient (INN):** Anifrolumab (Genetical Recombination)
- **Strength / unit:** ３００ｍｇ２ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 39 Other metabolic agents (その他の代謝性医薬品) › 399 Other metabolic agents (n.e.c.) (他に分類されない代謝性医薬品)
- **Manufacturer:** AstraZeneca (アストラゼネカ)
- **NHI price (reference only):** JPY 96068 per ３００ｍｇ２ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3999462A1028
- **JSON:** https://www.nifujipharma.com/api/drugs/3999462A1028

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Anifrolumab%20(Genetical%20Recombination)%20I.V.%20Infusion%20300mg%20(%E3%82%B5%E3%83%95%E3%83%8D%E3%83%AD%E3%83%BC%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%EF%BC%93%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%203999462A1028#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Anifrolumab (Genetical Recombination)

- [Anifrolumab (Genetical Recombination) S.C. Injection (サフネロー皮下注１２０ｍｇオートインジェクター)](https://www.nifujipharma.com/drugs/3999462G1020) — １２０ｍｇ０．８ｍＬ１キット, AstraZeneca